Overall rank by patents
#4,213
of 49,997 tracked assignees
USPTO PatentsView assignee record - 85 granted patents across 38 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, O&m ranks #4,213 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 38 technology areas.
USPTO PatentsView assignee plate
Corpus R4213 · US Corporation #4,213 · 85 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Macrogenics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Asahi Kasei Chemicals · near
51 score
Evonik Röhm · near
51 score
Lifetime Products · near
51 score
O&M Halyard · this assignee
51 score
Unitika · near
51 score
3D Lighting… · lowest
7 score
What this shows O&m's Innovation Score is 50.8/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
O&M Halyard, Inc. is a focused PatentsView assignee: 38 CPC subclasses with 40% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (22 grants) versus a trough of 5 in 2018. By volume, O&m sits between Macrogenics, Inc. and Pindrop Security, Inc..
From 2019–2021 to 2022–2024, O&M Halyard, Inc. moved from 47 to 28 grants (0.60x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Macrogenics, Inc.
85 patents
Nifco Korea Inc.
85 patents
NV Bekaert SA
85 patents
Nobel Biocare Services AG
85 patents
Océ Holding B.V.
85 patents
Omrix Biopharmaceuticals Ltd.
85 patents
Otto Bock Healthcare LP
85 patents
Pindrop Security, Inc.
85 patents
O&M Halyard, Inc.
85 patents
What this shows O&M holds 85 patents at rank #4,212, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,212 in granted patent volume.
Other assignees with the most granted patents in O&M's primary technology class.
Two PlainPatent-derived peer sets for O&M, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (51 here).
Nearest assignees by average claims per patent (16.0 here).
O&m's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 5 | 5.9% |
| 2019 | 10 | 11.8% |
| 2020 | 22 | 25.9% |
| 2021 | 15 | 17.6% |
| 2022 | 12 | 14.1% |
| 2023 | 11 | 12.9% |
| 2024 | 5 | 5.9% |
| 2025partial year | 5 | 5.9% |
Top 15 of 38 technology areas
Overall rank by patents
#4,213
of 49,997 tracked assignees
50.8 out of 100
What to do with this data
O&M Halyard, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.